# Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

> **NCT02862587** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai International Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Precision Cells
- Chemotherapy
- Advanced Lung Cancer

## Interventions

- **DRUG:** Chemotherapy
- **BIOLOGICAL:** precision cells

## Key facts

- **NCT ID:** NCT02862587
- **Lead sponsor:** Shanghai International Medical Center
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-03
- **Final completion:** 2018-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862587, "Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02862587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*